Changeflow GovPing Healthcare ResMed sleep disorder identification and treatm...
Routine Notice Added Final

ResMed sleep disorder identification and treatment systems

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Health Informatics (G16H)
Published
Detected
Email

Summary

The European Patent Office published patent EP4173005A1 for ResMed Pty Ltd, covering systems and methods for identifying individuals with sleeping disorders and disposition for treatment. The patent application includes IPC classifications G16H 50/20, A61B 5/00, G16H 10/60, and G16H 50/70. The designated states cover all relevant EU member states and extension countries.

What changed

The EPO published patent EP4173005A1 for ResMed Pty Ltd, covering systems and methods for identifying individuals with sleeping disorders and disposition for treatment. The patent was published April 1, 2026, and includes IPC classifications related to health informatics (G16H) and medical diagnostic devices (A61B). The patent designation covers all EU member states including AT, BE, DE, ES, FR, GB, IT, NL, and others.

Medical device manufacturers developing sleep disorder detection technology should review this patent to assess potential licensing needs or design-around options. Healthcare providers implementing sleep disorder screening systems should verify whether their current systems may fall within the scope of these claims.

What to do next

  1. Monitor patent portfolio for competitive landscape
  2. Review patent claims for potential infringement

Archived snapshot

Apr 8, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

SYSTEMS AND METHODS FOR IDENTIFYING INDIVIDUALS WITH A SLEEPING DISORDER AND A DISPOSITION FOR TREATMENT

Publication EP4173005A1 Kind: A1 Apr 01, 2026

Applicants

ResMed Pty Ltd

Inventors

ZOTELO, Natalie

IPC Classifications

G16H 50/20 20180101AFI20240521BHEP A61B 5/00 20060101ALI20240521BHEP G16H 10/60 20180101ALI20240521BHEP G16H 50/70 20180101ALI20240521BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for ChangeBridge: EPO Bulletin - Health Informatics (G16H)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
EPO
Published
April 1st, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4173005A1

Who this affects

Applies to
Medical device makers Healthcare providers Investors
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent grant Medical device development
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare Medical Devices

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Health Informatics (G16H) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.